Previous 10 | Next 10 |
New Harris Poll Reveals Significant Gaps in Women's Knowledge About Cervical Cancer PR Newswire FRANKLIN LAKES, N.J. , Jan. 5, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released fi...
Despite a challenging outlook for 2023, the setup for MedTech stocks looks favorable after three difficult years, argued Bank of America as the firm upgraded Becton, Dickinson ( NYSE: BDX ) and downgraded Baxter International ( NYSE: BAX ) on Tuesday. Citing macro concerns, th...
Summary This real-money portfolio wrapped up its eighth year with its best income-growing showing ever. Thanks to a dividend raise and several special payouts, ConocoPhillips was one of the DG50's star performers. Of the portfolio's holdings, Wells Fargo delivered the biggest divide...
The market forecasts for 2023 are all over the place, leaving many investors looking for reliable stocks with dependable dividends. That's particularly true now as the S&P 500 index has fallen more than 19% this year. CVS Health (NYSE: CVS) and Becton, Dickinson (NYSE: B...
Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend C...
Summary Becton, Dickinson had a flat year in 2022. Compared to the market, that was a strong result. Over the longer-term, Becton, Dickinson has been a solid compounder, but returns have lost some steam over the past five years. I believe the company can get back on track, and that ...
BD to Present at the 41st Annual J.P. Morgan Healthcare Conference PR Newswire FRANKLIN LAKES, N.J. , Dec. 20, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present a...
Summary Filled with high-quality, dividend-growing stocks, the DG50 easily beat the S&P 500 Index over the last year. This recent showing enabled my real-money portfolio to pull even with the market over its 8-year lifetime. Top performers since inception include Microsoft, Deer...
BD Releases 2022 Global Inclusion, Diversity and Equity Annual Report PR Newswire FRANKLIN LAKES, N.J. , Dec. 8, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the release of its s...
Summary Embecta Corp. signed an agreement with Intuity Medical to sell the POGO device last month. Market is positioning for further upside after Embecta reports its Q4 earnings on December 20th. We see no change to the available market data that suggests we should be sizing in Embe...
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials PR Newswire Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10 , 2024...